Massive digital gene expression analysis reveals different predictive profiles for immune checkpoint inhibitor therapy between adenocarcinoma and squamous cell carcinoma of advanced lung cancer

BACKGROUND: Immune checkpoint inhibitors prolong the survival of non-small cell lung cancer (NSCLC) patients. Although it has been acknowledged that there is some correlation between the efficacy of anti-programmed cell death-1 (PD-1) antibody therapy and immunohistochemical analysis, this technique...

Descripción completa

Detalles Bibliográficos
Autores principales: Kaneda, Toshihiko, Kurata, Takayasu, Yoshida, Tomoko, Kibata, Kayoko, Yoshioka, Hiroshige, Yanagimoto, Hiroaki, Takeda, Kazuhiko, Yoshida, Takao, Tsuta, Koji
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8822674/
https://www.ncbi.nlm.nih.gov/pubmed/35135489
http://dx.doi.org/10.1186/s12885-022-09264-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8822674/
https://www.ncbi.nlm.nih.gov/pubmed/35135489
http://dx.doi.org/10.1186/s12885-022-09264-2

Ejemplares similares